Abeona Therapeutics (ABEO) Prepaid Assets (2010 - 2026)
Abeona Therapeutics' (ABEO) quarterly Prepaid Assets came in at $2.0 million in Q1 2026, down 2.98% year-on-year from $2.0 million in Q1 2025, and up 50.77% quarter-over-quarter from $1.3 million in Q4 2025.
Abeona Therapeutics (ABEO) Prepaid Assets (2010 - 2026) Analysis & Trends
Abeona Therapeutics' Prepaid Assets history runs 17 years deep, the most recent figure standing at $2.0 million for Q1 2026.
- On a quarterly basis, Prepaid Assets fell 2.98% year-over-year to $2.0 million in Q1 2026; TTM through Mar 2026 was $2.0 million, a 2.98% decrease from a year earlier, with the FY2025 full-year figure at $1.3 million, up 13.21% from the prior year.
- Prepaid Assets advanced to $2.0 million in Q1 2026 per ABEO's latest filing, from $1.3 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $2.2 million in Q3 2025 and bottomed at $424000.0 in Q4 2022.
- The 5-year median for Prepaid Assets is $1.3 million (2025), against an average of $1.4 million.
- Across the five-year window, Prepaid Assets slumped 82.16% in 2022 and soared 119.8% in 2025, its largest moves.
- Year by year, Prepaid Assets stood at $424000.0 in 2022, then surged by 71.93% to $729000.0 in 2023, then soared by 56.79% to $1.1 million in 2024, then increased by 13.21% to $1.3 million in 2025, then soared by 50.77% to $2.0 million in 2026.
- Per Business Quant, the three latest ABEO Prepaid Assets figures stand at $2.0 million (Q1 2026), $1.3 million (Q4 2025), and $2.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Abeona Therapeutics | 107.85 Mn | -60.42 Mn | 6.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.95 Mn |
| Dec 31, 2025 | 1.29 Mn |
| Sep 30, 2025 | 2.21 Mn |
| Jun 30, 2025 | 2.09 Mn |
| Mar 31, 2025 | 2.01 Mn |
| Dec 31, 2024 | 1.14 Mn |
| Sep 30, 2024 | 1.01 Mn |
| Jun 30, 2024 | 1.22 Mn |
| Mar 31, 2024 | 1.81 Mn |
| Dec 31, 2023 | 729,000.00 |
| Sep 30, 2023 | 963,000.00 |
| Jun 30, 2023 | 1.20 Mn |
| Mar 31, 2023 | 1.62 Mn |
| Dec 31, 2022 | 424,000.00 |
| Sep 30, 2022 | 945,000.00 |
| Jun 30, 2022 | 1.44 Mn |
| Mar 31, 2022 | 2.00 Mn |
| Dec 31, 2021 | 2.38 Mn |
| Sep 30, 2021 | 907,000.00 |
| Jun 30, 2021 | 1.32 Mn |